PHARMACY

Digital pharmacy PillPack may open storefront near you

BY Michael Johnsen

BOSTON — Pharmacy startup PillPack is looking to augment its online pharmacy operation with brick-and-mortar locations with the infusion Wednesday of $50 million in financing led by CRV with participation from Accel Partners, Atlas Venture, Menlo Ventures and Sherpa Ventures. 
 
In addition to establishing a retail footprint in the U.S. market, the capital will be used to fuel growth and attract high-caliber talent, the company stated. 
 
"In the last two years, we've built and launched a better, simpler pharmacy experience that folks absolutely love," stated TJ Parker, CEO of PillPack. "With this funding, we're excited to expand our physical footprint across the country, enabling both increased capacity as well as opportunities for an even more delightful experience for our customers."
 
PillPack is a full-service pharmacy designed to simplify the process of managing multiple medications through a combination of personalized service, convenient packaging and technology. PillPack ships personalized rolls of pre-sorted prescriptions, vitamins and OTCs, in individual packs, and the company manages refills for customers by proactively coordinating with physicians and insurance providers.
 
PillPack has seen tremendous growth, shipping more than 1 million dose packs since the company's launch in February 2014. 
 
"In the last ten years, nearly every industry has been modernized to cater to its customers through convenience, service and simplicity. Surprisingly, the pharmacy experience has been completely overlooked," said George Zachary, partner at CRV. "I was drawn to PillPack because they've taken on this challenge. Anyone who has to deal with the hassles of an in-person retail pharmacy can understand its value, especially people who have to manage multiple prescriptions of their own or for their loved ones. It's truly transformative."
 
Zachary will take a director seat on the PillPack board, joining Fred Destin from Accel Partners, Jon Karlen from Atlas Venture and David Frankel from Founder Collective. PillPack has raised $62 million dollars to date.
 
PillPack is currently available in 47 states. The company accepts most prescription drug insurance plans, including a majority of Medicare Part D plans. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Mylan launches generic Seasonique

BY David Salazar

PITTSBURGH — Mylan announced on Tuesday that it had launched its generic version of Teva’s Seasonique birth control (Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg and Ethinyl Estradiol Tablets USP, 0.01 mg). The medication saw some $160.7 million in sales in the 12 months that ended on March 31 of this year. 
 
The launch follows the Food and Drug Administration’s approval of Mylan partner Famy Care’s abbreviated new drug application for the drug. Mylan has 271 ANDAs still awaiting FDA approvals, 47 of which are first-to-file opportunities. 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA approves Aurobindo’s Flagyl generic

BY DSN STAFF

Dayton, N.J. — Aurobindo Pharma Limited has received approval from the Food and Drug Administration for its generic equivalent to Flagyl (metronidazole) tablets in 250- and 500-mg dosage strengths.  
 
The medication is used to treat different types of infections resulting from particular types of bacteria and certain other infectious organisms. It can also be used to prevent infection during an operation. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?